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Abstract
Purpose: Emerging evidence implies that electromagnetic fields (EMFs) can
negatively affect angiogenesis. In this regard, the effects of extremely low
frequency pulsed electromagnetic field (ELF–PEMF) exposure on the relative
expression level of angiogenic factors involved in the pathogenesis of ocular
disorders were evaluated in human retinal pigment epithelial (hRPE) cells in order
to investigate a noninvasive therapeutic method for patients with several ocular
diseases associated with neovascularization.
Methods: After separating hRPE cells from globes, hRPE cells were exposed to
15 mT of ELF–PEMF (120 Hz) at 5, 10, and 15 min for seven days. Cell proliferation
and apoptosis of treated cells were evaluated via ELISA assay. Moreover, relative
expression changes of HIF-1α, CTGF, VEGFA, MMP-2, cathepsin D, and E2F3
were performed using real-time RT-PCR.
Results: ELF–PEMF exposure had no significant effects on the apoptosis and
proliferation rate of hRPE cells. Expression level of HIF-1α, CTGF, VEGFA, MMP-
2, cathepsin D, and E2F3 was downregulated following 5 min of ELF–PEMF
exposure.
Conclusion: As ELF–PEMF showed inhibitory effects on the expression of
angiogenic genes in hRPE cells with no cytotoxic or proliferative side effects,
it can be introduced as a useful procedure for managing angiogenesis induced
by retinal pathogenesis, althoughmore studies with adequate follow-up in animal
models are needed.
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INTRODUCTION
Neovascularization, a process of forming
new vessels occurs during physiological
development and also pathological events,
involved in several ocular diseases such as
age-related macular degeneration (AMD),
ischemic retinal vein occlusion, glaucoma,
corneal neovascularization secondary to chemical
injury or infection, diabetic retinopathy (DR),
and inflammatory processes.[1–3] Through the
production of different fibrotic and angiogenic
factors in choroidal neovascular membranes,
retinal pigment epithelial (RPE) cells contribute
to choroidal neovascularization (CNV) and
paracrine signaling between choriocapillaris
and RPE layer.[4–7] Hypoxia is an important
regulator of cell migration and angiogenesis,
especially under pathologic conditions, which
perform its action by upregulating hypoxia-
inducible factor 1 (HIF-1) and vascular endothelial
growth factor A (VEGFA).[8–11] VEGFA mainly
regulates angiogenesis, contributing to the
migration and proliferation of vascular endothelial
cells and tube formation, which increase
vascular permeability in angiogenesis.[12] The
VEGF/VEGFR signaling pathway is involved in
the activation of multiple angiogenic factors,
including matrix metalloproteinases (MMPs),
cathepsins, connective tissue growth factor
(CTGF), and E2Fs.[13, 14] CTGF can help regulation
of the extracellular matrix (ECM) turnover and a
relationship is found between CTGF and CNV.[15] In
addition, matrix-degrading proteinases including
MMPs and cathepsins induce angiogenesis
through facilitating endothelial cell penetration in
the subendothelial matrix.[16, 17]
Suppression of relative angiogenic factors
in ocular pathologic conditions can prevent
angiogenesis and visual impairment.[19, 20] In
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the treatment of proliferative ocular diseases,
anti-VEGF is applied as an intraocular
agent.[21] Besides, in many studies, HIF-1[22]
and MMPs[23] was introduced as therapeutic
targets for retinal-related neovascularization
diseases
Several studies have shown that
electromagnetic fields can be used as therapeutic
options, implicating the biological effects of
extremely low frequency pulsed electromagnetic
fields (ELF–PEMFs) with respect to their
amplitude, frequency, and exposure time.[24–26]
Many investigations have demonstrated the
effects of ELF–PEMFs on the apoptosis,
proliferation, differentiation, angiogenic and
metastatic properties of different cells.[27–29]
This study aimed to determine the ELF–
PEMF effects on the angiogenic factors in
human RPE (hRPE) cells in different exposure
times.
METHODS
Sample Preparation and Cell Culture
Four eye globes from four human neonatal
donors with the age of 2–12 months and death
enucleation time of < 24 hr, were provided by
the Central Eye Bank of Iran. Then posterior
segments were cut by removing the iris and
vitreous body carefully. Thereafter, the sensory
retina was removed after the posterior eyes were
dissected into four quadrants. After removing the
RPE/choroid layer from the sclera, incubation was
carried out for 60 min in 2% dispase solution
with 5% CO2 at 37°C. Then, centrifugation was
performed at 300 g for five min at 4°C in order
to achieve cell pellet. Cell pellet was cultured in
25 cm2 flasks with DMEM/F12 medium (Sigma-
Aldrich, Germany), supplemented with 10% FBS
at 37°C with 5% CO2. Finally, the confluent
cells from passages 2–5 were used for all the
experiments.
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Immunocytochemistry
Immunocytochemistry with hRPE cell-specific
antibodies was performed in order to characterize
hRPE cells from the donated eyes. After culturing
the hRPE cells at 5×103 cells/well in 24-well
plates, they were fixed by methanol (–10°C)
at room temperature for 10 min. Then, the
cells were permeabilized using Triton X-100
(0.25%) and blocked with 1% bovine serum
albumin in PBS at room temperature for 60
min.
After irrigating with PBS to remove the blocking
agent, the cells were incubated with a 1:1000
mouse monoclonal IgG2a anti-human cytokeratin
8/18 antibody labeling epithelial cells, as well as
a 1:100 rabbit polyclonal IgG anti-human RPE65
antibody labeling RPE microsomal membranes
(Santa Cruz, CA, USA) overnight at 4°C. The
fluorescein isothiocyanate (FITC)-conjugated
antibodies (1:100 goat anti-mouse and anti-
rabbit IgGs; Santa Cruz, CA, USA) were added
for 45 min in darkness at room temperature
following irrigation with PBS. Finally, to stain
the nucleus, the cells were incubated with 1.5
mg/ml of DAPI (Santa Cruz, CA, USA) for 10
min. To capture images of the labeled cells,
an inverted fluorescence microscope (Olympus
IX71, Japan) was used with two filters for FITC-
conjugated antibodies and DAPI (520 and 460
nm, respectively).
ELF–PEMF Treatment
Similar to previous studies on PEMFs, an exposure
system was provided by Shahid Beheshti
University of Medical Sciences (Department of
Nuclear Medicine, Tehran, Iran). The magnetic
field device contains a controller, and Helmholtz
coils consisted of two parallel identical coils (22
cm apart) at 22 cm radius of the curvature. Each
coil was constructed by winding 800 turns of
1-mm insulated soft copper wire. The flasks with
the confluent hRPE cells was placed between
the polar faces of the coils at 37°C with 5% CO2,
and exposure time on each day was 5, 10, and
15 min for three cultures. The experiment was
performed at a magnetic intensity of 15 mT (120
Hz, 92 V) during one week. Immediately after
exposure, ELISA assays and RNA extraction were
done.
ELISA Cell Proliferation and Cell Death
Assays
Following ELF–PEMF exposure to the cultured
hRPE cells, proliferation and apoptosis of cells
were assessed using ELISA BrdU and ELISA PLUS
kits (Roche, Germany) based on the instructions,
respectively. For this experiment, the cultured
hRPE cells in passage two were used at a cell
density of 1×103/ml in a 96-well plate. Proliferation
and apoptosis assays of treated cells and control
cells were performed in triplicate per cultivated
hRPE cell from each donated eye. With respect
to cell death ELISA assay, the reading results of
the ELF–PEMF-treated cells were compared to
the untreated cells and the positive control (a
complex of DNA and histone) included in the kit.
Absorption of the samples was read at specific
wavelengths, using an ELx 808 absorbance reader
(BioTek Instruments, VT, USA).
RNA Isolation and Real-Time RT-PCR
In order to analyze gene expression changes of
HIF-1α, CTGF, VEGFA, MMP-2, cathepsin-D, and
E2F3 in ELF–PEMF-treated hRPE cells total RNA
extraction of the treated and control cells was
performed by TRIzol reagent (Ambion, USA). The
cells were incubated for five min using TRIzol
at room temperature. After adding chloroform to
separate RNA, isopropanol (500 μl) was added for
RNA precipitation and rinsed with 75% ethanol.
Finally, using nuclease-free water, RNA pellet
was dissolved. Spectrophotometry analysis was
performed using a NanoDrop (Thermo Fisher
Scientific, USA) to determine the concentration
and purity of the extracted RNAs (A260/280
concentrations). RNA integrity was evaluated by
clearly observing 28S and 18S rRNA bands using
agarose gel electrophoresis.
The SuperScript reverse transcriptase kit and
oligo dT primers (Invitrogen, USA) were used for
reverse transcription synthesis of the extracted
RNAs in both treated and control cells. Afterward
an EvaGreen master mix (Solis BioDyne, Estonia)
was used for real-time RT-PCR assay. Specific
primers for relative genes and GAPDH, as a
housekeeping gene, were used, and efficiency (E)
was evaluated for each primer according to the
slope of the standard curve. Table 1 presents the
primer sequences.
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Cathepsin D TGTGGAGGACCTGATTGC CGAAGACGACTGTGAAGC
The PCR conditions included an amplification
cycle of 94°C for 12 min; 40 cycles of denaturation,
amplification, and quantification for 15 s at 95°C,
58-64°C for 30 s, and finally 72°C for 25 s. Also,
melting curve analysis was performed at 65°C
to 95°C with a gradual increase. RT-PCR assay
was carried out in three separate analyses. Every
sample was examined in duplicate.
Statistical Analysis
The results of the ELISA and real-time RT-PCR
are presented as mean ± SD of three separate
experiments. Kolmogorov Smirnov test was used
to check the normal distribution of the data. To
compare ELF–PEMF-treated hRPE cultures and
control groups, we used Mann–Whitney or t-test.
P < 0.05 was considered statistically significant.
RESULTS
hRPE Cell Identification
The RPE cells were cultured in a DMEM/F12
medium (1:1), containing FBS 10% (v/v). After
removing the culture medium at 80% confluence
within oneweek, it was subjected to thementioned
ICC protocol. The cultured hRPE cells showed
immunoreactivity for cytokeratin 8/18 (Figure 1A-1C)
and RPE65 (Figure 1D-1F), confirming their identity.
Cell Proliferation and Cell Death Evaluation
Effects of ELF–PEMF on the cell proliferation
and apoptosis of hRPE cells were examined by
ELISA. The findings showed that ELF–PEMF did not
influence cell proliferation (Figure 2). As well, no
cytotoxic effect was reported in the treated cells in
comparison with the controls (Figure 3).
Gene Expression Analysis
The expression levels of HIF-1α, CTGF, VEGFA,
MMP-2, cathepsin-D, and E2F3 after ELF–PEMF
exposure of hRPE cells in comparison with the
controls were evaluated by real-time RT-PCR. Effect
of ELF–PEMF on mRNA expression was evaluated
in three intervals (5, 10, and 15 min). The expression
level of all genes significantly reduced in hRPE cells
in comparison with the controls after 5 min (Figure
4 and Figure 5, P< 0.05). At 10 min, the expression
levels of VEGFA and MMP-2 were significantly
increased in hRPE cells after ELF–PEMF exposure
compared to the controls. However, after 15 min,
only the expression level of E2F3 decreased
while CTGF, VEGFA and MMP-2 were significantly
increased in treated hRPE cells in comparison with
the control group (Figure 6).
DISCUSSION
ELF–PEMF exposure had not any cytotoxic
and proliferative effects on the hRPE cells,
that in combination with negative impacts
on the angiogenic factors, the future of this
noninvasive treatment strategy for neovascular
eye diseases will be promising. The balance
between proangiogenic and antiangiogenic
factors is essential for normal angiogenesis.
However, in pathogenic conditions, the imbalance
is perturbed.[30] Pathological retinal angiogenesis
induced by hRPE cells in diseases, such as AMD
and DR, eventually leads to visual loss. Therefore,
it is necessary to be controlled and treated.[31]
VEGFA as a key molecule in ocular diseases
[32], is a downstream factor of HIF-1 transcription
factor. HIF-1 can increase the expression of VEGFA
that promotes cell proliferation and migration
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Figure 1. Immunocytochemistry of hRPE cells indicating RPE cell identity. Cytokeratin 8/18 expression confirms the epithelial
origin of the cultures, and RPE65 expression confirms that isolated cells are RPE cells. (A) RPE cells stained positively for
the fluoresceinisothiocyanate (FITC)-conjugated cytokeratin antibody (green). (B) Nuclei stained blue with 4,6-diamidino-2-
phenyindole dihydrochloride (DAPI). (C) Merged image (FITC-labeled cytokeratin and DAPI; 200X). (D) RPE cells stained positively
for the RPE65 antibody (green). (E) DAPI-stained RPE cell nuclei (blue). (F) Merged image (FITC-labeled RPE65 and DAPI; 200X).
Figure 2. Effect of ELF–PEMF on the proliferation rate of hRPE cells. hRPE cells exposed to ELF–PEMF; After 7 days and each day
5, 10, and 15 min of exposure at a magnetic intensity of 15 mT (120 Hz, 92 V), Cultures were harvested and proliferation assay was
performed according to the manufacturer’s instructions for cell proliferation ELISA assay. Proliferation rate of hRPE cell cultures
did not changed under exposure to ELF–PEMF compared to non-treated control cultures (P > 0.05).
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Figure 3. Exploring the cytotoxic effects of ELF–PEMF on hRPE cells. Exposure time on each day was 5, 10, and 15 min and was
performed at a magnetic intensity of 15 mT (120 Hz, 92 V) during one week. After exposure, cultures were harvested and subjected
to cell death assay according to the manufacturer’s instructions for cell death ELISA assay. Results indicated that ELF–PEMF did
not has any cytotoxic effects on the treated hRPE cells compared to the positive control provided by the kit (P > 0.05).
through its related receptors.[33] In addition,
VEGFA is an upstream factor of CTGF and can
upregulate its expression, which is a proangiogenic
factor in several organs. Furthermore, it is linked
to pathological fibrosis, such as vitreoretinal
disorders including AMD and DR.[15, 34, 35] It was
demonstrated that in diabetic rats, the expression
level of CTGF was upregulated in the retina.[36]
Moreover, the expression of many angiogenic
mediators, such as cathepsins and MMPs, is
induced by VEGFA and CTGF.[37, 38] In addition,
in the early phases of angiogenic process, ECM
degradation by MMPs and cathepsin proteases is
commonly performed.[39]
There is an increasing interest in the therapeutic
potential of ELF–PEMFs for patients with diseases
associated with neovascularization.[27, 40, 41] It was
previously reported that ELF–PEMFs negatively
affect angiogenesis in breast cancer.[42] In addition,
it was demonstrated that VEGFR2 expression and
activation, which is an important factor in vascular
formation by endothelial cells, decreased following
ELF–PEMFs treatment.[26]
Moreover, it was shown that ELF–PEMFs
activate stress proteins, including heat-shock
proteins (e.g., HSP90, and HSP70), changing the
half-life, activity or expression of proteins, such
as VEGFR1 and VEGFR2.[27, 43–47] In addition, it
was demonstrated that ELF–PEMF stimulation
significantly decreased the renal expression
of VEGFA.[48] In the current study, ELF–PEMF
negatively affected the expression of VEGFA,
HIF-1α, CTGF, MMP-2, cathepsin-D, and E2F3 as
angiogenic factors. Therefore, ELF–PEMF can
be investigated as a novel therapeutic approach
for retinal neovascular disorders. The mentioned
antiangiogenic effect was after 5-min treatment,
at 10 min, results were reversed and ELF–PEMF
acted as an angiogenic agent! VEGFA and MMP-2
were increased significantly in the treated cultures.
At 15 min, in addition to VEGFA and MMP-2,
CTGF significantly was increased compared to the
untreated cultures. Based on the results, the effect
of ELF–PEMF on hRPE cells is time-dependent.
Besides, in different articles effects of ELF–PEMF
was shown to be dependent on more parameters
such as cell type, frequency and flux density.[48, 49]
Emerging evidence suggests the use of ELF–PEMF
in therapy still requires a lot of research.
CONCLUSION
We observed that ELF–PEMFs have significant
inhibitory roles on the expression of angiogenic
factors in the hRPE cells, as pivotal cells in ocular
health and disease. Therefore, ELF–PEMFs can
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Figure 4. Box plot analysis of HIF-1α, CTGF, VEGFA, MMP-2, cathepsin D and E2F3 expression in hRPE cell cultures exposed
to ELF–PEMF as treated cultures compared to hRPE cell cultures without ELF–PEMF as control cultures. After 5 min, RNA was
extracted, and gene expression analysis was performed by quantitative real-time RT–PCR as described in the methods section.
mRNA levels were normalized to GAPDH and presented as log2 fold change of the control values. Expression levels of all the
genes were significantly reduced in the treated hRPE cells compared to the control cultures (P < 0.05).
Figure 5. Box plot analysis of HIF-1α, CTGF, VEGFA, MMP-2, cathepsin D and E2F3 expression in hRPE cell cultures exposed
to ELF–PEMF as treated cultures compared to hRPE cell cultures without ELF–PEMF as control cultures. After 10 min, RNA was
extracted, and gene expression analysis was performed by quantitative real-time RT–PCR as described in the methods section.
mRNA levels were normalized to GAPDH and presented as log2 fold change of the control values. Expression levels of VEGFA
and MMP-2 were significantly increased in hRPE cells after ELF–PEMF exposure compared to the controls (P < 0.05).
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Figure 6. Box plot analysis of HIF-1α, CTGF, VEGFA, MMP-2, cathepsin D and E2F3 expression in hRPE cell cultures exposed
to ELF–PEMF as treated cultures compared to hRPE cell cultures without ELF–PEMF as control cultures. After 15 min, RNA was
extracted, and gene expression analysis was performed by quantitative real-time RT–PCR as described in the methods section.
mRNA levels were normalized to GAPDH and presented as log2 fold change of the control values. Expression levels of CTGF,
VEGFA and MMP-2 were significantly increased, while E2F3 was significantly decreased in treated hRPE cells compared to the
controls (P < 0.05).
be used for therapeutic applications in ocular
diseases, but field strengths, frequencies, and
exposure times must be considered. Also, further
studies should be done to evaluate important
genes and factors altered by ELF–EMF in different
settings and situations.
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